Taro Pharmaceutical Indus Analyst Ratings
HC Wainwright Adjusts Price Target on Taro Pharmaceutical Industries to $35 From $54, Maintains Buy Rating
Taro Pharmaceutical Indus Analyst Ratings
Taro Pharmaceutical Inds Price Target Cut to $54.00/Share From $73.00 by HC Wainwright & Co.
Taro Pharmaceutical Inds Is Maintained at Buy by HC Wainwright & Co.
Taro Pharmaceutical Indus analyst ratings
HC Wainwright & Co. Maintains Buy on Taro Pharmaceutical Indus, Lowers Price Target to $54
No Data